GHK Basic (Tripeptide-1): molecular data, studies & sources

Molecular formula, weight & structure

Registered clinical trials

Studies registered on ClinicalTrials.gov that list GHK Basic as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human intervention studies

Selected studies in which participants received GHK Basic, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

1. Research publication · design requires review

   Glycyl-l-histidyl-l-lysine prevents copper- and zinc-induced protein aggregation and central nervous system cell death in vitro.

   Min JH, Sarlus H, Harris RA et al. · Metallomics : integrated biometal science · 2024

   PMID 38599632 · DOI: 10.1093/mtomcs/mfae019

2. Research publication · design requires review

   Relief of ovalbumin-induced airway remodeling by the glycyl-l-histidyl-l-lysine-Cutripeptide complex via activation of SIRT1 in airway epithelial cells.

   Zhang Q, Liu J, Deng MM et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

   PMID 37257226 · DOI: 10.1016/j.biopha.2023.114936

3. Research publication · design requires review

   Effects of the tripeptide glycyl-L-histidyl-L-lysine copper complex on osteoblastic cell spreading, attachment and phenotype.

   Godet D, Marie PJ · Cellular and molecular biology (Noisy-le-Grand, France) · 1995

   PMID 8747089

4. Research publication · design requires review

   Structure of the Glycyl-L-histidyl-L-lysine--copper(II) complex in solution.

   Freedman JH, Pickart L, Weinstein B et al. · Biochemistry · 1982

   PMID 6291585 · DOI: 10.1021/bi00262a004

5. Research publication · design requires review

   In vitro evaluation of compression-coated glycyl-L-histidyl-L-lysine-Cu(II) (GHK-Cu2+)-loaded microparticles for colonic drug delivery.

   Uğurlu T, Türkoğlu M, Özaydın T et al. · Drug development and industrial pharmacy · 2011

   PMID 21457130 · DOI: 10.3109/03639045.2011.569934

GHK Basic (Tripeptide-1) supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

No priced supplier offers are currently available in this catalog view. The research record remains available independently of stock.

Reference sources & further reading

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

Related research profiles